- E89.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E89.3 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E89.3 – other international versions of ICD-10 E89.3 may differ.
ICD-10-CM E89.3 is grouped within Diagnostic Related Group(s):
- 643 Endocrine disorders with mcc
- 644 Endocrine disorders with cc
- 645 Endocrine disorders without cc/mcc
Applicable To
- Postirradiation hypopituitarism
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E89.3:
- acquired > pituitary gland (congenital) Q89.2
- hypopituitarism > postprocedural E89.6
- hypopituitarism (posthypophysectomy) > surgical procedure (on) T81.9
- iatrogenic (postprocedural) > pituitary gland E23.7
- due to > Hypopituitarism (juvenile) E23.0
- hypophysectomy > due to E89.3
- radiotherapy > due to E89.3
- postirradiation > Hypopituitarism (juvenile) E23.0
- postprocedural > Hypopituitarism (juvenile) E23.0